Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 28, 2026	Feb. 28, 2025	Feb. 28, 2026	Feb. 28, 2025
Cash Flows from Operating Activities:
Net loss	$ (3,705,901)	$ (1,377,044)	$ (17,836,235)	$ (1,504,505)
Adjustments to reconcile net loss to net cash used in operations
Amortization of debt discount			546,021	85,106
Inducement expense	2,918,050		10,176,450
Stock-based compensation			5,797,611	1,050,000
Warrants issued for services			88,000
Changes in operating assets and liabilities:
Overdraft			1,172
Accounts payable			163,358	45,000
Accrued interest payable			104,948	5,219
Due to related parties			3,282	1,187
Net Cash Used In Operating Activities			(955,393)	(317,993)
Cash Flows from Financing Activities:
Note Payable borrowings			955,000	565,000
Proceeds from sale of common stock				1,000
Net Cash Provided by Financing Activities			955,000	566,000
Net (Decrease) in Cash and Restricted Cash			(393)	248,007
Cash and Restricted Cash at Beginning of Period			393	2,743
Cash and Restricted Cash at End of Period		250,750		250,750
Cash		750		750
Restricted Cash		250,000		250,000
Total Cash and Restricted Cash at End of Period		$ 250,750		250,750
Supplemental disclosure of cash flow information: Non-cash investing and financing activities
Shares issued with convertible notes				548,750
Shares issued as inducement			10,176,450
Shares issued for services			5,797,611
Warrants granted			$ 634,021